Article info
Letter
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination
- Correspondence to Dr Giuseppe A Ramirez, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, via Olgettina 60, 20132 Milano, Italy; ramirez.giuseppealvise{at}hsr.it
Citation
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination
Publication history
- Received May 23, 2022
- Accepted July 13, 2022
- First published August 3, 2022.
Online issue publication
September 12, 2022
Article Versions
- Previous version (3 August 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.